Sofia de la Riva-Fernandez

Learn More
BACKGROUND/AIMS To determine the changes in the incidence of diabetic retinopathy (DR), diabetic macular oedema (DMO) and their risk factors in a population-based study of patients with diabetes mellitus (DM) referred to our 16 Primary Health Care Areas (HCAs). METHODS Prospective population-based study of a total of 15 396 Caucasian patients with DM, who(More)
BACKGROUND Prospective, population-based study of an 8-year follow up. To determine the direct cost of diabetic retinopathy [DR], evaluating our screening programme and the cost of treating DR, focusing on diabetic macular oedema [DMO] after anti-vascular endothelial growth factor [anti-VEGF] treatment. METHODS A total of 15,396 diabetes mellitus [DM](More)
  • 1